Physician profile
Amy Groff
NPI 1922068568
$6,316.21
in general payments reported to CMS, 2019-2025
49 companies · $1,633 in 2025
The $1,633 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $562 · 2020: $280 · 2021: $1,060 · 2022: $781 · 2023: $1,090 · 2024: $910 · 2025: $1,633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,543 · Education: $90.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,542.65 |
| Education | $90.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $831.38 | 2021-2025 | |
| Abbvie INC. | $733.75 | 2019-2025 | |
| Astellas Pharma US INC | $486.85 | 2019-2025 | Veozah, Myrbetriq |
| Bayer Healthcare Pharmaceuticals INC. | $414.77 | 2019-2025 | |
| Medtronic, INC. | $341.37 | 2021-2024 | Minimed 780g |
| Novo Nordisk INC | $322.54 | 2022-2025 | Wegovy |
| Biogen, INC. | $320.00 | 2024-2025 | Zurzuvae |
| Evofem Biosciences, INC. | $319.62 | 2020-2025 | Phexxi, Solosec, Phexx |
| Pfizer INC. | $307.61 | 2019-2025 | |
| Organon LLC | $235.75 | 2022-2025 | Nexplanon, Jada System |
| Exeltis, USA INC. | $211.41 | 2025 | Slynd, Twirla |
| Therapeuticsmd, INC. | $171.49 | 2019-2022 | |
| Hologic Sales and Service, LLC | $141.59 | 2022-2025 | Aptima, Novasure, Acessa Provu System |
| Coopersurgical, INC. | $130.04 | 2019-2024 | Paragard T 380a, Summit Doppler, Endosee |
| Merck Sharp & Dohme LLC | $91.75 | 2019-2021 |
Show all 48 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Groff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.